Your browser doesn't support javascript.
loading
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Morra, Anna; Schreurs, Maartje A C; Andrulis, Irene L; Anton-Culver, Hoda; Augustinsson, Annelie; Beckmann, Matthias W; Behrens, Sabine; Bojesen, Stig E; Bolla, Manjeet K; Brauch, Hiltrud; Broeks, Annegien; Buys, Saundra S; Camp, Nicola J; Castelao, Jose E; Cessna, Melissa H; Chang-Claude, Jenny; Chung, Wendy K; Colonna, Sarah V; Couch, Fergus J; Cox, Angela; Cross, Simon S; Czene, Kamila; Daly, Mary B; Dennis, Joe; Devilee, Peter; Dörk, Thilo; Dunning, Alison M; Dwek, Miriam; Easton, Douglas F; Eccles, Diana M; Eriksson, Mikael; Evans, D Gareth; Fasching, Peter A; Fehm, Tanja N; Figueroa, Jonine D; Flyger, Henrik; Gabrielson, Marike; Gago-Dominguez, Manuela; García-Closas, Montserrat; García-Sáenz, José A; Genkinger, Jeanine; Grassmann, Felix; Gündert, Melanie; Hahnen, Eric; Haiman, Christopher A; Hamann, Ute; Harrington, Patricia A; Hartikainen, Jaana M; Hoppe, Reiner; Hopper, John L.
Afiliação
  • Morra A; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Schreurs MAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Anton-Culver H; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Augustinsson A; Department of Medicine, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, California, USA.
  • Beckmann MW; Oncology, Clinical Sciences in Lund, Lund University, Lund, Sweden.
  • Behrens S; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
  • Bojesen SE; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bolla MK; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Brauch H; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Broeks A; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Buys SS; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Camp NJ; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Castelao JE; iFIT-Cluster of Excellence, University of Tübingen, Tübingen, Germany.
  • Cessna MH; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Tübingen, Germany.
  • Chang-Claude J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Chung WK; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Colonna SV; Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
  • Couch FJ; Intermountain Healthcare, Salt Lake City, Utah, USA.
  • Cox A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cross SS; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Czene K; Departments of Pediatrics and Medicine, Columbia University, New York, New York, USA.
  • Daly MB; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
  • Dennis J; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Devilee P; Department of Research, Vestre Viken Hospital, Drammen, Norway.
  • Dörk T; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Dunning AM; Division of Surgery, Cancer and Transplantation Medicine, Department of Oncology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
  • Dwek M; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
  • Easton DF; Oslo Breast Cancer Research Consortium, Oslo University Hospital, Oslo, Norway.
  • Eccles DM; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Eriksson M; Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway.
  • Evans DG; Core Facility for Biobanking, The Arctic University of Norway, Tromsø, Norway.
  • Fasching PA; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Fehm TN; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Figueroa JD; Department of Oncology and Metabolism, Sheffield Institute for Nucleic Acids (SInFoNiA), University of Sheffield, Sheffield, UK.
  • Flyger H; Department of Neuroscience, Academic Unit of Pathology, University of Sheffield, Sheffield, UK.
  • Gabrielson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Gago-Dominguez M; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • García-Closas M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • García-Sáenz JA; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
  • Genkinger J; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Grassmann F; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Gündert M; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Hahnen E; School of Life Sciences, University of Westminster, London, UK.
  • Haiman CA; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Hamann U; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Harrington PA; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Hartikainen JM; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Hoppe R; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Hopper JL; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Cancer Med ; 12(15): 16142-16162, 2023 08.
Article em En | MEDLINE | ID: mdl-37401034
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article